COMBINATION ANALGESIC OPIOID PAIN THERAPY

• US 20110046173A1
• Filed: 09/25/2009
• Published: 02/24/2011
• Est. Priority Date: 08/24/2009
• Status: Abandoned Application

• Current Assignee: Qrxpharma Ltd.
• Original Assignee: Patricia Tewes Richards, Warren Charles Stern
• Inventors: Stern, Warren Charles, Richards, Patricia Tewes
• Application Number:
  US12/567,209
• Publication Number:
  US 20110046173A1
• Time in Patent Office: Days
• US Class Current: 514/282
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/485 Morphinan derivatives, e.g. morphine, codeine

Abstract

Provided are pharmaceutical compositions and methods for the alleviation of pain in a patient with ratios of morphine and oxycodone that provide lower incidence of adverse side effects compared to equi-analgesic doses of morphine and oxycodone alone. The pharmaceutical compositions comprise an analgesic amount of morphine and an analgesic amount of oxycodone, or pharmaceutically acceptable salts thereof, in ratios of about 3 to 2 to about 1.25 to 1, morphine to oxycodone by weight.

Claims

1. An analgesic pharmaceutical composition comprising morphine and oxycodone, or pharmaceutically acceptable salts thereof, in a ratio of from about 3 to 2 to about 1.25 to 1, morphine to oxycodone by weight, optionally in combination with a pharmaceutically acceptable carrier, wherein the morphine and oxycodone are each present in analgesic amounts.

2. The pharmaceutical composition of claim 1, wherein the composition comprises pharmaceutically acceptable salts of morphine and oxycodone.

3. The pharmaceutical composition of claim 1, wherein the ratio of morphine to oxycodone is about 3 to 2.

4. The pharmaceutical composition of claim 1, wherein the composition is in the form of a solid oral dosage form.

5. The pharmaceutical composition of claim 4, wherein the dosage form comprises an immediate release formulation.

6. The pharmaceutical composition of claim 4, wherein the dosage form comprises a controlled release formulation.

7. The pharmaceutical composition of claim 4, wherein the dosage form is a tablet or capsule.

8. The pharmaceutical composition of claim 1, wherein the composition is in a liquid oral dosage form.

9. The pharmaceutical composition of claim 1, wherein the composition is in a liquid intravenous or sub-cutaneous dosage form.

10. The pharmaceutical composition of claim 1, wherein the morphine and oxycodone are present in amounts of about 3 mg morphine and about 2 mg oxycodone, about 6 mg morphine and about 4 mg oxycodone, about 12 mg morphine and about 8 mg oxycodone or about 18 mg morphine and about 12 mg oxycodone.

11. A method for the alleviation of pain in a patient comprising administering to the patient the pharmaceutical composition of claim 1.

12. The method composition of claim 11, wherein the ratio of morphine to oxycodone is about 3 to 2.

13. A method for the alleviation of pain in a patient comprising administering to the patient a pharmaceutical composition comprising morphine and oxycodone, or pharmaceutically acceptable salts thereof, in a ratio of from about 3 to 2 to about 1.25 to 1, morphine to oxycodone by weight, optionally in combination with a pharmaceutically acceptable carrier, wherein the morphine and oxycodone are each present in analgesic amounts.

14. The pharmaceutical composition of claim 13, wherein the composition comprises pharmaceutically acceptable salts of morphine and oxycodone.

15. The method of claim 13, wherein the ratio of morphine to oxycodone is about 3 to about 2.

16. The method of claim 13, wherein the morphine and oxycodone are present in amounts of about 3 mg morphine and about 2 mg oxycodone, about 6 mg morphine and about 4 mg oxycodone, about 12 mg morphine and about 8 mg oxycodone and about 18 mg morphine and about 12 mg oxycodone.

17. The method of claim 16, wherein the composition is administered orally.

18. The method of claim 13, wherein the composition is administered orally, rectally, parenterally, sublingually, buccally, intravenously, intraarticularly, intramuscularly, intradermally, subcutaneously, intraocularly, intraperitoneally, epidurally, transdermally or by inhalation.